# data[].attributes.body
IvWatch is a small device that is placed above an IV site that uses analytical algorithms and infrared technology to detect if there has been intravenous infiltration or extravasation in adults or pediatric patients. The sensor can detect as little as 0.2 mL of fluid and an average of 2 to 3 mL of fluid. (ivWatch, 2019) The device is a small sticker that allows for flexibility for different IV insertion sites, and is then connected to a twelve foot fiber-optic cable that can be attached to the monitor. The monitor will alert the medical care team if there is less than 1 mL of fluid surrounding the vein and will turn bright yellow on the monitor screen. If there is further change from baseline after the IV site has been checked by the health care team, the monitor will turn bright red. These settings allow the health care team to be notified of changes in the IV site even when a change is not visible to the naked eye.
https://www.medgadget.com/2018/03/ivwatch-detects-iv-infiltrations-and-extravasations-interview-with-gary-warren-president-and-ceo.html

# data[].attributes.body
https://youtu.be/GU-UsAfwjsY

# data[].attributes.attachment_link.title
How Does ivWatch Detect IV Infiltrations?

# data[].attributes.body
ivWatch, LLC. (2019, April 3 – 2019, April 9). ivWatch Sensor: Device Validation for Infiltrated Tissues. Identifier NCT04064229. https://clinicaltrials.gov/study/NCT04064229

McBride, C., et al. (2022). Comparing ivWatch Biosensor to Standard Care to Identify Extravasation Injuries in the Pediatric Intensive Care: A Protocol for a Randomized Controlled Trial, 12(2). DOI: https://doi.org/10.1136/bmjopen-2020-047765

Medgadget Editors. (2020). ivWatch Monitors IV Placement Sites for Leakage, Now Cleared by FDA. https://www.medgadget.com/2020/07/ivwatch-monitors-iv-placement-sites-for-leakage-cleared-by-fda.html

Van Rens M., et al. (2019). A new approach for early recognition of peripheral intravenous (PIV) infiltration: a pilot appraisal of a sensor technology in a neonatal population. Vascular Access 2019; 5(2):38-41. DOI: https://doi.org/10.33235/va.5.2.38-41

# data[].attributes.attachment_link.readable_text
ivWatch, a company based in Newport News, Virginia, won FDA clearance for its SmartTouch sensor that detects peripheral IV infiltration and extravasation events. Though somewhat rare, these can be difficult to notice and a late response can lead to grave consequences. The SmartTouch sensor can warn physicians that something is wrong, sometimes hours before a clinician would notice any visual or tactile changes on the patient's body.

The sensor, which is already cleared in Europe, is a single-use disposable device that can be used on patients of any age, including those in the neonatal intensive care unit. Thanks to the SmartTouch, clinicians can take advantage of additional options in terms of where to place the IV, which is especially important for neonates, to choose longer dwell times, and to keep an eye on active patients that may be ambulatory at times.

The device, which uses visible and near-infrared light to penetrate the skin, can be used alongside the ivWatch Patient Monitor that algorithmically analyzes the optical signatures of tissue around the IV site while compensating for patient movements. The system can detect changes as small as .2 mL of IV fluid, with an average detection volume of 2.02 mL, according to ivWatch. Any adverse events are immediately relayed to the clinical team for a quick response.

The adhesive on the back side of the sensor is breathable, leading to minimal irritation and compatibility with existing IV dressings.

More from ivWatch regarding the tested efficacy of the SmartTouch:

A series of seven IRB-approved studies were conducted to test the efficacy and safety of the SmartTouch Sensor. Five verification studies were conducted to understand the performance and optimize ivWatch's proprietary algorithm to maximize sensitivity to infiltrated tissues, while limiting the number of false notifications issued. Two validation studies were conducted to investigate device sensitivity and false notification rates.

Clinical data shows that the SmartTouch Sensor issued notifications for 99.0%* of early stage infiltrations in less than 10 mL of infused IV fluid. Results also showed less than one false notification was issued every six days, therefore having minimal contribution to clinician alarm fatigue.[3],[4],[5] The majority of the non-infiltration notifications were attributed to a force applied to the IV site, which may beneficially notify clinicians of conditions that could place the peripheral IV site at a greater risk for complications. ivWatch also has a proven record of detecting IV infiltrations an average of 15 hours before the clinician.[2]

Flashbacks: ivWatch Detects IV Infiltrations and Extravasations: Interview with Gary Warren, President and CEO; ivWatch Monitors IV Placement Sites for Leakage Outside Veins; ivWatch IV Infiltration Detection Device Cleared in Europe; ivWatch Detects Leaks Near IV Placement Sites;

Product page: SmartTouch Sensor

Via: ivWatch

# data[].attributes.attachment_link.title
ivWatch Monitors IV Placement Sites for Leakage, Now Cleared by FDA |

# data[].attributes.attachment_link.description
ivWatch, a company based in Newport News, Virginia, won FDA clearance for its SmartTouch sensor that detects peripheral IV infiltration and extravasation events. Though somewhat rare, these can be difficult to notice and a late response can lead to grave consequences.

# data[].attributes.body
Not economically feasible for every department.

It is not 100% accurate. The device showed a 93.3% accuracy, although very accurate, there is still possibility of missing an infiltrated IV (Van Rens M et al., 2019).

The health care team may begin to rely too heavily on the monitoring system and not check the patients IV site as often or at all with the system unless alerted.

# data[].attributes.body
The health care team is notified in real time when there is a change in the intravenous site.

This will decrease time in which patient injury can occur.

This will allow the health care team to act quicker on the damaged site and remove the infiltrated IV and alert the health care provider if treatment is needed.

Patients who are unable to speak due to intubation, age or medical condition may not be able to communicate when they are having pain at IV site, with the IvWatch, it breaks down those barriers in communication.

It is easily used, the sensor is flexible and can be place in any part of the body.

It is latex free for those with allergies (ivWatch, 2019).

It is compatible with MRI machines (ivWatch, 2019).

# data[].attributes.body
Working in the Emergency Department, it is very easy to get caught up with a certain patient and not be able to check on other patients for a prolonged amount of time. The IvWatch allows for the nurse to be able to comfortably step away from their patient for the time being and know their patient will be getting their transfusion of medications safely. In my opinion, the largest population this device will be useful for will be for the pediatric patients in the ER. It is very difficult to get a good IV on pediatric patients under one years old and it is very common that their IV's will infiltrate. Typically a pediatric patient needs to be very sick to receive an IV and blood work and usually receive more vesicant drugs. This device will aid in decreasing patient harm for all patients but mainly for pediatrics who have no voice when they are in pain and have not been checked on for a prolonged amount of time.

# data[].attributes.body
My five personal strengths are strategic, empathy, belief, discipline and developer.

Strategic: Being Strategic will allow me to help my team when unexpected conflicts occur and will help guide them to find possible solutions.

Empathy: Being an empathizer, this will help me to take into account the feelings of each team member and will help promote a more positive working environment where everyone can feel heard even if their idea is not chosen.

Developer: This will help to utilize everyones ideas and assistance while making it all cohesive for the project at hand.

Belief: Having the strength of "belief" demonstrates that I am passionate about things and will put in my all to make sure the project will do well.

Discipline: Having discipline will help to keep the team on track and make sure that everything gets done when needed.

# data[].attributes.body
The team members I chose that wound benefit the team the most are as follows.

Chelsea: Chelsea's strength is command which makes her beneficial to the team because there needs to be a designated leader of the group and her strength will help her to handle situations well and lead the group overall.

Carter: Carters strength is communication which will help the team by helping to communicate the innovation well and present the material concisely and clearly.

Faith: Faith is futuristic which will allow a fresh perspective the the team.

Matthew: Matthew is a maximizer which aids in the cohesiveness of group work and help everyone work together more efficiently.

William: Williams strength is Woo, which will allow networking with other people for the team and creating a more positive environment among team members.